Henry James International Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Sell |
49,210
-2,900
| -6% | -$200K | 1.12% | 29 |
|
|
2025
Q1 | $3.62M | Sell |
52,110
-39
| -0.1% | -$2.71K | 1.24% | 27 |
|
|
2024
Q4 | $4.49M | Sell |
52,149
-7
| -0% | -$602 | 1.62% | 20 |
|
|
2024
Q3 | $6.21M | Sell |
52,156
-3,608
| -6% | -$430K | 2.16% | 13 |
|
|
2024
Q2 | $7.96M | Buy |
55,764
+2,021
| +4% | +$288K | 2.82% | 11 |
|
|
2024
Q1 | $6.9M | Buy |
53,743
+6,796
| +14% | +$873K | 2.13% | 13 |
|
|
2023
Q4 | $4.86M | Buy |
46,947
+3
| +0% | +$310 | 1.82% | 18 |
|
|
2023
Q3 | $4.27M | Buy |
46,944
+36,980
| +371% | +$3.36M | 1.85% | 19 |
|
|
2023
Q2 | $806K | Buy |
9,964
+3,500
| +54% | +$283K | 0.35% | 56 |
|
|
2023
Q1 | $514K | Buy |
+6,464
| New | +$514K | 0.22% | 81 |
|